US 6740638
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
expired A61KA61K38/00A61P
Quick answer
US patent 6740638 (Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein) held by Neurocrine Biosciences, Inc. expires Mon May 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue May 25 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61P, A61P25/00, A61P25/28